MartinSebastianAllen-AuerbachMD

Nuclear Medicine • Los Angeles, CA

Associate Professor, Molecular & Medical Pharmacology, UCLA School of Medicine

Join to view full profile

Dr. Allen-Auerbach is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Allen-Auerbach's full profile

Already have an account?

Office
200 UCLA Medical Plz Ste B114
Los Angeles, CA 90095
Phone+1 310-794-1005

Fax+1 310-267-0227

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 2002 - 2003
New York Downtown HospitalResidency, Internal Medicine, 1999 - 2002
University of Vienna Faculty of MedicineClass of 1995

Certifications & Licensure

CA State Medical License 2002 - 2026
American Board of Nuclear Medicine Nuclear Medicine

Clinical Trials

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
No longer available
18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions Start of enrollment: 2015 Jun 12
Terminated

Publications & Presentations

PubMed

51 citations
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI with histopathology gold-standard in the detection, intra-prostatic localization and local extension of primar...
Ida Sonni, Ely Felker, Andrew T. Lenis, Anthony Sisk, Shadfar Bahri
Journal of Nuclear Medicine. 2021-10-14
22 citations
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Sarah M Larson, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek
Cancer Discovery. 2023-03-01
239 citations
Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
Johannes Czernin, Martin Allen-Auerbach, Heinrich R. Schelbert
Journal of Nuclear Medicine. 2007-01-01

Press Mentions

UCLA Health Earns Comprehensive Center of Excellence Designation for Radiopharmaceutical Therapy as Work Continues on New FacilityJune 29th, 2022
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialJune 1st, 2019

Other Languages

German, Spanish